Fluticasone furoate/vilanterol 200/25Â mcg in Asian asthma patients: A randomized trial

FF/VI improved evening PEF over 12 weeks versus FP in Asian patients, with a similar safety profile. The results are generally consistent with a global study comparing the same treatments.